Analysis of CD34+ subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose but steady state levels do not correlate with bone marrow reserve

Guy Pratt, AC Rawstron, AE English, Roderick Johnson, AS Jack, GJ Morgan, GM Smith

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In peripheral blood stem cell transplantation (PBSCT), the number of CD34+ cells transplanted has been shown to correlate well with both rapidity and durability of engraftment. However, it is clear that engraftment does not necessarily correlate with total CD34+ cell numbers in some patients. Consequently, there is increasing interest in evaluating the role of CD34+ subsets in haemopoietic recovery as a more accurate marker of harvest quality. We analysed the numbers of CD34+ cell subsets, namely Thy-1+, L-Selectin+ and CD38-, and correlated this with engraftment in 86 patients undergoing PBSCT. Adequate engraftment was defined as being a platelet count greater than 50 x 10(9)/l and a neutrophil count greater than 1.0 x 10(9)/l. CD34+L-Selectin+ provided the best prediction of engraftment rapidity, although the improvement over total CD34+ cell dose was minor. Only the dose of CD34+Thy-1+ cells transplanted correlated with durable engraftment. The probability of adequate 3-month engraftment increased with the dose of CD34+ cells transplanted, but 10% of patients receiving > 5 x 10(6)/kg still showed poor engraftment at 3 months. However, all patients receiving > 2.5 x 10(5)/kg CD34+Thy-1+ showed adequate engraftment at this time point. We also demonstrated that CD34+Thy-1+ progenitors were restricted to the bone marrow under normal conditions and, during stem cell mobilization, their kinetics generally paralleled total CD34+ numbers.
Original languageEnglish
Pages (from-to)937-943
Number of pages7
JournalBritish Journal of Haematology
Volume114
DOIs
Publication statusPublished - 1 Sept 2001

Fingerprint

Dive into the research topics of 'Analysis of CD34+ subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose but steady state levels do not correlate with bone marrow reserve'. Together they form a unique fingerprint.

Cite this